Advanced Viral Research CP (ADVR) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Advanced Viral Research CP (ADVR)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bernie Bildman who wrote (1849)	12/10/1996 5:15:00 PM
From: Mark Chavez	of 2281

To all - the latest news may be more significant than Hirschman's paper as Reticulose has now shown some efficacy in vivo, and proper placebo controls were run. A dose-response curve would be nice, as well as some marker or indication of where the metabolic breakdown of Reticulose occurs. At any rate, consider the release to be a step in the right direction. Mark.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next